Life Sciences Research for Lifelong Health



Babraham Institute Joins Alliance for European Excellence and Competitiveness in Life Science

The Babraham Institute has recently joined an alliance of 13 top European research centres in life sciences to foster excellence in research, share knowledge and influence policy.  Partners in the alliance, called EU-LIFE, are renowned research centres that operate with similar principles of excellence, external reviews, independence, competitiveness and internationality.  During difficult economic times and within a highly competitive research landscape, they believe that they can join forces to better address complex questions, thereby contributing to pushing European science forward.

85 EU-LIFE members (including 8 from the Babraham Institute) recently attended two EU-LIFE events at the Centre for Genomic Regulation (CRG) in Barcelona: The first EU-LIFE Scientific Workshop on the Biology of Cancer, and the second EU-LIFE community meeting.  The EU-LIFE scientific workshop brought together basic scientists and clinicians from EU-LIFE institutes (and collaborators) to explore and discuss new directions in cancer biology.  During the second community meeting, Institute representatives joined working groups on Grants, Science Communication, Translational Research, Technology Transfer, Training, Information Technology and Indicators of Excellence (Strategy), to share best practice and benefit from each other’s expertise and experience in these domains.

Current partners of this alliance are the co-leaders Center for Genomic Regulation (CRG, Spain) and VIB (Belgium), the Institut Curie (France), the Max Delbrück Center for Molecular Medicine (MDC Berlin-Buch, Germany), Instituto Gulbenkian de Ciência (IGC,Portugal), Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM, Austria), the European Institute of Oncology (IEO, Italy), the Central European Institute of Technology (CEITEC, Czech Republic), the Netherlands Cancer Institute (Netherlands), the Institute for Molecular Medicine Finland (FIMM, Finland), the Biotech Research and Innovation Centre (BRIC, Denmark), the Babraham Institute (United Kingdom), the Friedrich Miescher Institute for Biomedical Research (FMI, Switzerland).

CONTACT: Linden Smith Knowledge Exchange Manager Email:
Tel:       +44 (0)1223 496260  The Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT United Kingdom


9 June, 2014